During the past decade, Mestska nemocnice Ostrava conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mestska nemocnice Ostrava" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Institute of Health Information and Statistics of the Czech Republic" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mestska nemocnice Ostrava" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Brno University Hospital" with 1 trials as a collaborator and "Centre of Cardiovascular and Transplantation Surgery, Czech Republic" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Mestska nemocnice Ostrava" are "Coronary Artery Disease" (2 trials), "Ulcerative Colitis" (2 trials), "Acute Myocardial Infarction With ST-segment Elevation" (1 trials), "Atrial Fibrillation" (1 trials) and "Coronary Heart Disease (CHD)" (1 trials). Many other conditions were trialed in "Mestska nemocnice Ostrava" in a lesser frequency.

Most popular intervention types in "Mestska nemocnice Ostrava" are "Drug" (5 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Etrolizumab" (2 trials), "Aspirin" (1 trials), "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials), "Clopidogrel or Ticagrelor" (1 trials) and "DNA testing" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mestska nemocnice Ostrava" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Mestska nemocnice Ostrava". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Mestska nemocnice Ostrava, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mestska nemocnice Ostrava, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Mestska nemocnice Ostrava has several departments that took part in Clinical trials: "Kardiologická ambulance" - 2 trials